The Challenge of Predicting Which Children with Attention Deficit-Hyperactivity Disorder Will Respond Positively to Methylphenidate

Journal of Applied Developmental Psychology

Volumn 21, Issue 5, 2000, Pages 471-489

  Gray, Jeremy R ^a   Kagan, Jerome ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042686534     PISSN: 01933973     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-3973(00)00050-2     Document Type: Article

References (126)

1. Aman M.G., Kern R.A., McGhee D.E., Arnold L.E. Fenfluramine and methylphenidate in children with mental retardation and ADHD. Clinical and side effects Journal of the American Academy of Child and Adolescent Psychiatry. 32(4):1993;851-859.
2. Aman M.G., Kern R.A., Osborne P., Yumuluru R., Rojahn J., del Medico V. Fenfluramine and methylphenidate in children with mental retardation and borderline IQ. Clinical effects American Journal of Mental Retardation. 101:1997;521-534.
3. Aman M.G., Marks R.E., Turbott S.H., Wilsher C.P., Merry S.N. Clinical effect of methylphenidate and thioridazine in intellectually subaverage children. Journal of the American Academy of Child and Adolescent Psychiatry. 30(2):1991;246-256.
4. Aman M.G., Turbott S.H. Prediction of clinical response in children taking methylphenidate. Journal of Autism and Developmental Disorders. 21:1991;211-228.
5. Diagnostic and statistical manual of mental disorders. 4th ed:1994;Author, Washington, DC.
6. Anderson J.R. Arguments concerning representation for mental imagery. Psychological Review. 85:1978;249-277.
7. Anderson K.J., Revelle W. Impulsivity and time of day. Is rate of change in arousal a function of impulsivity? Journal of Personality and Social Psychology. 67(2):1994;334-344.
8. Arnold L.E., Votolato N.A., Kleykamp D., Baker G.B., Bornstein R.A. Does hair zinc predict amphetamine improvement of ADD/hyperactivity? International Journal of Neuroscience. 50(1-2):1990;103-107.
9. Arnsten A.F., Goldman-Rakic P.S. Noise stress impairs prefrontal cortical cognitive function in monkeys. Evidence for a hyperdopaminergic mechanism Archives of General Psychiatry. 55(4):1998;362-368.
10. Barkley R.A. Predicting the response of hyperactive children to stimulant drugs. A review Journal of Abnormal Child Psychology. 4(4):1976;327-348.
11. Barkley R.A. A review of stimulant drug research with hyperactive children. Journal Child Psychology and Psychiatry. 18:1977;137-165.
12. Barkley R.A. Attention deficit hyperactivity disorder. A handbook for diagnosis and treatment:1990;Guilford, New York.
13. Barkley R.A. Impaired delayed responding. A unified theory of attention deficit hyperactivity disorder Routh D.K. Disruptive behavior disorders. Essays in honor of Herbert Quay:1994;11-57 Plenum, New York.
14. Barkley R.A. ADHD and the nature of self-control. 1997;Guilford, New York. a.
15. Barkley R.A. Behavioral inhibition, sustained attention, and executive functions. Constructing a unifying theory of ADHD Psychological Bulletin. 121:1997;65-94. b.
16. Barkley R.A., Cunningham C.E. The effects of methylphenidate on the mother-child interactions of hyperactive children. Archives of General Psychiatry. 36:1979;201-208.
17. Barkley R.A., Grodzinsky G., DuPaul G.J. Frontal lobe functions in attention deficit disorder with and without hyperactivity. A review and research report Journal of Abnormal Child Psychology. 20(2):1992;163-188.
18. Barkley R.A., Jackson T.L. Hyperkinesis, autonomic nervous system activity and stimulant drug effects. Journal of Child Psychology and Psychiatry. 18:1977;347-357.
19. Barkley R.A., McMurray M.B., Edelbrock C.S., Robbins K. The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry. 28(6):1989;873-881.
20. Bawden D. Predicting methylphenidate response with neurometric testing. Case studies Koziol L.F., Stout C.E., Ruben D.H. Handbook of childhood impulse disorders and ADHD. Theory and practice:1993;60-77 Charles C. Thomas, Springfield, IL.
21. Bedi G.C., Halperin J.M., Sharma V. Investigation of modality-specific distractibility in children. International Journal of Neuroscience. 74:1994;79-85.
22. Beery, S. H. (1994). Behavioral disinhibition, anxiety and response to methylphenidate and behavior intervention in children with attention deficit hyperactivity disorder. Unpublished doctoral dissertation, University of Miami, Coral Gables, Florida.
23. Bekaroglu M., Aslan Y., Gedik Y., Deger O., Mocan H., Erduran E., Karahan C. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder. A research note Journal of Child Psychology and Psychiatry. 37(2):1996;225-227.
24. Biederman J., Faraone S.V., Keenan K., Benjamin J., Krifcher B., Moore C., Sprich-Buckminster S., Ugaglia K., Jellinek M.S., Steingard R., Spencer T., Norman D., Kolodny R., Kraus I., Perrin J., Keller M.B., Tsuang M. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Archives of General Psychiatry. 49:1992;728-738.
25. Biederman J., Lapey K., Milberger S., Faraone S.V., Reed E.D., Seidman L.J. Motor preference, major depression and psychosocial dysfunction among children with attention deficit hyperactivity disorder. Journal of Psychiatry Research. 28(2):1994;171-184.
26. Biederman J., Milberger S., Faraone S.V., Kiely K., Guite J., Mick E., Ablon S., Warburton R., Reed E. Family-environment risk factors for attention-deficit hyperactivity disorder. Archives of General Psychiatry. 52:1995;464-470.
27. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-932.
28. Buitelaar J.K., van der Gaag R.J., Swaab-Barneveld H., Kuiper M. Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 34(8):1995;1025-1032.
29. Carey W.B. Problems in diagnosing attention and activity. Pediatrics. 103:1998;664-667.
30. Carlson G.A., Rapport M.D., Kelly K.L., Pataki C.S. Methylphenidate and desipramine in hospitalized children with comorbid behavior and mood disorders. Separate and combined effects on behavior and mood Journal of Child and Adolescent Psychopharmacology. 5(3):1995;191-204.
31. Casey B.J., Castellanos F.X., Giedd J.N., Marsh W.L., Hamburger S.D., Schubert A.B., Vauss Y.C., Vaituzis A.C., Dickstein D.P., Sarfatti S.E., Rapoport J.L. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 36(3):1997;374-383.
32. Castellanos F.X., Elia J., Kruesi M.J.P., Marsh W.L., Gulotta C.S., Potter W.Z., Ritchie G.F., Hamburger S.D., Rapoport J.L. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Neuropsychopharmacology. 14:1996;125-137.
33. Conners C.K. The effect of stimulant drugs on human figure drawings in children with minimal brain dysfunction. Psychopharmacologia. 126:1971;329-333.
34. Conners C.K. Psychological effects of stimulant drugs in children with minimal brain dysfunction. Pediatrics. 49:1972;702-708.
35. Cook E.H., Stein M.A., Leventhal B.L. Family-based association of attention-deficit/hyperactivity disorder and the dopamine transporter. Blum K., Noble E.P. Handbook of psychiatric genetics. 1997;297-310 CRC Press, Boca Raton, FL.
36. de Sonneville L.M.J., Njiokitjien C., Bos H. Methylphenidate and information processing. Part I - Differentiation between responders and nonresponders; Part II - Efficacy in responders. Journal of Clinical and Experimental Neuropsychology. 16(6):1994;877-897.
37. Denckla M.B. Biological correlates of learning and attention. What is relevant to learning disability and attention-deficit hyperactivity disorder? Developmental and Behavioral Pediatrics. 17:1996;114-119.
38. Denney, C. B. (1997). Predictive models of methylphenidate response in children with Attention-Deficit Hyperactivity Disorder: Premises, implications, and an empirical evaluation. Unpublished doctoral dissertation, University of Hawaii, Honolulu.
39. Diamond A. Evidence for the importance of dopamine for prefrontal cortex functions early in life. Philosophical Transactions of the Royal Society of London B. 351:1996;1483-1493.
40. Douglas V.I., Barr R.G., Amin K., O'Neill M.E., Britton B.G. Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. Journal of Child Psychology and Psychiatry. 29(4):1988;453-475.
41. DuPaul G.J., Barkley R.A., McMurray M.B. Response of children with ADHD to methylphenidate. Interaction with internalizing symptoms Journal of the American Academy of Child Psychiatry. 33:1994;894-903.
42. Effron D., Jarman F., Barker M. Methylphenidate versus dextroamphetamine in children with attention deficit hyperactivity disorder. A double-blind, crossover trial Pediatrics. 100(6):1997;E6.
43. Elia J., Borcherding B.G., Rapoport J.L., Keysor C.S. Methylphenidate and dextroamphetamine treatments of hyperactivity. Are there true nonresponders? Psychiatry Research. 36:1991;141-155.
44. Elia J., Breck G., Borcherding B.G., Potter W.Z., Mefford I.N., Rapoport J.L., Keysor C.S. Stimulant drug treatment of hyperactivity. Biochemical correlates Clinical Pharmacology & Therapy. 48:1990;57-66.
45. Ferguson H.B., Trites R.L. Predicting the response of hyperactive children to Ritalin. An empirical study Knights R.M., Bakker D.J. Treatment of hyperactive and learning disordered children. 1980;249-257 University Park Press, Baltimore.
46. Gray J.A. The neuropsychology of anxiety. An enquiry into the functions of the septo-hippocampal system:1982;Oxford University Press, Oxford.
47. Gualtieri C.T., Hicks R.E., Evans R.W., Patrick K. The clinical importance of methylphenidate blood level determinations. Bloomingdale L.M. Attention deficit disorder (Vol. 3). 1988;81-100 Pergamon Press, New York.
48. Gualtieri C.T., Wargin W., Kanoy R., Patrick K., Shen C.D., Youngblood W., Mueller R.A., Breese G.R. Clinical studies of MPH serum levels in children and adults. Journal of the American Academy of Child Psychiatry. 21(1):1982;19-26.
49. Halliday R., Callaway E., Rosenthal J.H. The visual ERP predicts clinical response to methylphenidate in hyperactive children. Psychophysiology. 21(1):1984;114-121.
50. Halliday R., Gnauck K., Rosenthal J.R., McKibben J.L., Callaway E. The effects of methylphenidate on school and home behavior of the hyperactive child. Knights R.M., Bakker D.J. Treatment of hyperactive and learning disordered children. 1980;237-247 University Park Press, Baltimore, MD.
51. Halperin J.M., Gittelman R., Katz S., Struve F.A. Relationship between stimulant effect, electroencephalogram, and clinical neurological findings in hyperactive children. Journal of the American Academy of Child and Adolescent Psychiatry. 25(6):1986;820-825.
52. Handen B.L., Breaux A.M., Gosling A., Ploof D.L., Feldman H. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder. Pediatrics. 86(6):1990;922-930.
53. Handen B.L., Feldman H., Gosling A., Breaux A.M., McAuliffe S. Adverse side effects of methylphenidate among mentally retarded children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 30:1991;241-245.
54. Handen B.L., Janosky J., McAuliffe S., Breaux A.M., Feldman H. Prediction of response to methylphenidate among children with ADHD and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry. 33(8):1994;1185-1193.
55. Heilman K.M., Voeller L.L., Nadeau S.E. A possible pathophysiological substrate of attention deficit hyperactivity disorder. Journal of Child Neurology. 6(Suppl.):1991;S76-S81.
56. Hicks E., Gualtieri C.T., Mayo J.P., Schroeder S.R., Lipton M.A. Methylphenidate and homeostasis. Drug effects on the cognitive performance of hyperactive children Bloomingdale L.M. Attention deficit disorder. Identification, course and treatment rationale:1985;131-141 Spectrum, New York.
57. Hinshaw S.P., Hencker B., Whalen C.K., Erdhardt D., Dunnington R.E. Aggressive, prosocial, and nonsocial behavior in hyperactive boys. Dose effects of methylphenidate in naturalistic settings Journal of Consulting and Clinical Psychology. 57:1989;636-643.
58. Jackson S.R., Marrocco R., Posner M.I. Networks of anatomical areas controlling visuospatial attention. Neural Networks. 7(6/7):1994;925-944.
59. Janowsky J.S., Carper R. Is there a neural basis for cognitive transitions in school-age children? Sameroff A.J., Haith M.M. The five to seven year shift. 1996;33-60 University of Chicago Press, Chicago, IL.
60. John E.R., Prichep L.S., Almas M. Subtyping of psychiatric patients by cluster analysis of QEEG. Brain Topography. 4(4):1992;321-326.
61. Jonkman L.M., Verbaten M.N., de Boer D., Maes R.A.A., Buitelaar J.K., Kemner C., van Engeland H., Koelega H.S. Difference in plasma concentrations of the D- and L-threo methylphenidate enantiomers in responding and non-responding children with attention deficit hyperactivity disorder. Psychiatry Research. 78:1998;115-118.
62. Kagan J. Reflection-impulsivity. The generality and dynamics of conceptual tempo Journal of Abnormal Psychology. 71:1966;17-24.
63. Kaplan S.L., Busner J., Kupietz S., Wasserman E., Segal B. Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH. A preliminary report Journal of the American Academy of Child and Adolescent Psychiatry. 29:1990;719-723.
64. Kaufman A.S. A new approach to the interpretation of test scatter on the WISC-R. Journal of Learning Disabilities. 9:1976;160-168.
65. Khan A.U., Dekirmenjian H. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome. American Journal of Psychiatry. 138(1):1981;108-110.
66. Kidder, K. R. (1990). Factorial analysis of WISC-R subtest scatter scores of attention deficit hyperactivity disordered children and adolescents: A predictor of positive Ritalin responders? Unpublished doctoral dissertation, George Washington University, Washington, DC.
67. Kinsbourne M. Base-state dependency of stimulant effects on the cognitive performance of hyperactive children. Bloomingdale L.M. Attention deficit disorder. Identification, course, and treatment rationale:1985;143-154 Spectrum, New York.
68. Klein R.G., Wender P. The role of methylphenidate in psychiatry. Archives of General Psychiatry. 52:1995;429-433.
69. Klorman R., Brumaghim J.T., Fitzpatrick P.A., Borgstedt A.D., Strauss J. Clinical and cognitive effects of methylphenidate on children with attention deficit disorder as a function of aggression/oppositionality and age. Journal of Abnormal Psychology. 103(2):1994;206-221.
70. Klorman R., Brumaghim J.T., Salzman L.F., Strauss J., Borgstedt A.D., McBride M.C., Loeb S. Effects of methylphenidate on children with attention-deficit hyperactivity disorder with and without aggression/non-compliant features. Journal of Abnormal Psychology. 97:1988;413-422.
71. Klorman R., Brumaghim J.T., Salzman L.F., Strauss J., Borgstedt A.D., McBride M.C., Loeb S. Comparative effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive noncompliant features. Psychopharmacology Bulletin. 25(1):1989;109-113.
72. Klorman R., Coons H.W., Borgstedt A.D. Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder. I. Clinical findings Journal of the American Academy of Child and Adolescent Psychiatry. 26(3):1987;363-367.
73. Knopp W., Arnold E., Andras R., Smeltzer D. Predicting amphetamine response in hyperkinetic children by electronic pupillography. Pharmacopsychiatry. 6:1973;158-166.
74. Kosslyn S.M., Koenig O. Wet mind. The new cognitive neuroscience:1992;Free Press, New York.
75. Livingstone R.L., Dykman R.A., Ackerman P.T. Psychiatric comorbidity and two doses of methylphenidate in children with attention deficit disorder. Journal of Child and Adolescent Psychopharmacology. 2:1992;115-122.
76. Loney J. Predicting stimulant response among hyperactive children. Psychiatric Annals. 16:1986;16-19.
77. Loney J., Langhorne J.E., Paternite C.E. An empirical basis for subgrouping the hyperkinetic/minimal brain dysfunction syndrome. Journal of Abnormal Psychology. 87(4):1978;431-441. a.
78. Loney J., Prinz R., Mishalow J., Joad J. Hyperkinetic/aggressive boys in treatment. Predictors of clinical response to methylphenidate American Journal of Psychiatry. 135:1978;1487-1491. b.
79. Luciana M., Collins P.F., Depue R.A. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex. 8(3):1998;218-226.
80. 2 dopamine receptor agonist. Journal of Cognitive Neuroscience. 4(1):1992;58-68.
81. Matier K., Halperin J.M., Sharma V., Newcorn J.H., Sathaye N. Methylphenidate response in aggressive and nonaggressive ADHD children. Distinctions on laboratory measures of symptoms Journal of the American Academy of Child and Adolescent Psychiatry. 31:1992;219-225.
82. McBride M.C. An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder. Journal of Pediatrics. 113:1988;137-145.
83. Mick E., Biederman J., Faraone S.V. Is season of birth a risk factor for attention-deficit hyperactivity disorder? Journal of the American Academy of Child and Adolescent Psychiatry. 35(11):1996;1470-1476.
84. Milberger S., Biederman J., Faraone S.V., Chen L., Jones J. Is maternal smoking during pregnancy a risk factor for attention-deficit hyperactivity disorder in children? American Journal of Psychiatry. 153(9):1996;1138-1142.
85. Nolan E.E., Gadow K.D. Relation between ratings and observations of stimulant drug response in hyperactive children. Journal of Clinical Child Psychology. 23(1):1994;78-90.
86. Pelham W.E., Milich R. Individual differences in response to methylphenidate in classwork and social behavior. Greenhill L.L., Osman B.B. Ritalin. Theory and patient management:1991;203-221 Mary Ann Liebert, New York.
87. Pelham W.E., Walker J.L., Sturges J., Hoza J. Comparative effects of methylphenidate on ADD girls and ADD boys. Journal of the American Academy of Child and Adolescent Psychiatry. 28:1989;773-776.
88. Peloquin L.J., Klorman R. Effects of methylphenidate on normal children's mood, event-related potentials, and performance in memory scanning and vigilance. Journal of Abnormal Psychology. 95(1):1992;88-98.
89. Pliszka S.R. The effects of anxiety on cognition, behavior, and stimulant response in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 28(6):1989;882-887.
90. Quay H.C. Attention deficit disorder and the behavioral inhibition system. The relevance of the neuropsychological theory of Jeffrey A. Gray Bloomingdale L.M., Sergeant J. Attention deficit disorder. Criteria, cognition, intervention:1988;117-126 Pergammon, New York.
91. Quay H.C. Inhibition and attention deficit hyperactivity disorder. Journal of Abnormal Child Psychology. 25(1 7-13):1997.
92. Rapoport J.L., Buchsbaum M., Weingartner H., Zahn T., Ludlow C., Mikkelsen E. Dextroamphetamine. Cognitive and behavioral effects in normal and hyperactive boys and normal men Archives of General Psychiatry. 37:1980;933-943.
93. Rapoport J.L., Buchsbaum M., Zahn T., Weingartner H., Ludlow C., Mikkelsen E. Dextroamphetamine. Cognitive and behavioral effects in normal prepubertal boys Science. 199:1978;560-562.
94. Rapport M.D., Denney C. Titrating methylphenidate in children with attention-deficit/hyperactivity disorder. Is body mass predictive of clinical response? Journal of the American Academy of Child & Adolescent Psychiatry. 36:1997;523-530.
95. Rapport M.D., Denney C., DuPaul G.J., Gardner M.J. Attention deficit disorder and methylphenidate. Normalization rates, clinical effectiveness, and response prediction in 76 children Journal of the American Academy of Child & Adolescent Psychiatry. 33(6):1994;882-893.
96. Rapport M.D., DuPaul G.J., Kelly K.L. Attention deficit hyperactivity disorder and methylphenidate. The relationship between gross body weight and drug response in children Psychopharmacology Bulletin. 25:1989;285-290.
97. Rapport M.D., DuPaul G.J., Stoner G., Jones J.T. Comparing classroom and clinic measures of attention deficit disorder. Differential, idiosyncratic, and dose-response effects of methylphenidate Journal of Consulting and Clinical Psychology. 54(3):1986;334-341.
98. Safer D.J., Zito J.M., Fine E.M. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 98(6 Pt 1):1996;1084-1088.
99. Sameroff, A. J., & Haith, M. M. (Eds.) (1996). The five to seven year shift: The age of reason and responsibility. Chicago, IL: University of Chicago Press.
100. Sawaguchi T., Goldman-Rakic P.S. The role of D1-dopamine receptor in working memory. Local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task Journal of Neurophysiology. 71(2):1994;515-528.
101. Schachar R.J., Tannock R., Logan G. Inhibitory control, impulsiveness, and attention deficit hyperactivity disorder. Clinical Psychology Review. 13:1993;721-739.
102. Schachar R.J., Tannock R., Marriott M., Logan G. Deficient inhibitory control in attention deficit hyperactivity disorder. Journal of Abnormal Child Psychology. 23:1995;411-438.
103. Sergeant J.A., van der Meere J. What happens after a hyperactive child commits an error? Psychiatry Research. 24(2):1988;157-164.
104. Sergeant J., van der Meere J. Convergence of approaches in localizing the hyperactivity deficit. Lahey B.B., Kazdin A.E. Advances in clinical child psychology (Vol. 13). 1990;207-240 Elsevier, New York.
105. Servan-Schreiber D., Carter C.S., Bruno R.M., Cohen J.D. Dopamine and the mechanisms of cognition. Part II. D-amphetamine effects in human subjects performing a selective attention task Biological Psychiatry. 43(10):1998;723-729.
106. Shekim W.O., Dekirmenjian H., Chapel J.L. Urinary MHPG excretion in minimal brain dysfunction and its modifications by d-amphetamine. American Journal of Psychiatry. 136:1979;667-671.
107. Shekim W.O., Javaid J., Davis J.M., Bylund D.B. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Biological Psychiatry. 18:1983;707-714.
108. Shen Y., Wang Y. Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome. Biological Psychiatry. 19(6):1984;861-870.
109. Sprague R.L., Sleator E.K. Methylphenidate in hyperkinetic children. Differences in dose effects on learning and social behavior Science. 198:1977;1274-1276.
110. Suffin S.C., Emory W.H. Neurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic outcome. Clinical Electroencephalography. 26(2):1995;76-83.
111. Sunohara G.A., Voros J.G., Malone M.A., Taylor M.J. Effects of methylphenidate in children with attention deficit hyperactivity disorder. A comparison of event-related potentials between medication responders and non-responders International Journal of Psychophysiology. 27:1997;9-14.
112. Swanson J.M. Measurement of serum concentration and behavioral responses in ADHD children to acute doses of methylphenidate. Bloomingdale L.M. Attention deficit disorder (Vol. 3). 1988;107-126 Pergamon Press, New York.
113. Swanson J.M., Kinsbourne M., Roberts W., Zucker K. Time-response analysis of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics. 61:1978;21-29.
114. Tannock R., Ickowicz A., Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child and Adolescent Psychiatry. 34(7):1995;886-896.
115. Taylor E. Drug response and diagnostic validation. Rutter M. Developmental neuropsychiatry. 1983;348-368 Guilford, New York.
116. Taylor E., Schachar R., Thorley G., Wieselberg H.M., Everitt B., Rutter M. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behavior. Psychological Medicine. 17:1987;121-143.
117. Thomson, J. B. (1992). Prediction of stimulant response in children with ADHD. Unpublished doctoral dissertation, University of Victoria, Victoria, BC, Canada.
118. Tirosh E., Elhasid R., Cohen-Bar Kamah S., Cohen A. Predictive value of placebo methylphenidate. Pediatric Neurology. 9:1993;131-133.
119. Varley C.K., Trupin E.W. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder. A preliminary study American Journal of Mental Deficiency. 86(6):1982;560-566.
120. Voelker S., Lachar D., Gdowski C.L. The Personality Inventory for Children and response to methylphenidate. Preliminary evidence for predictive utility Journal of Pediatric Psychology. 8(2):1983;161-169.
121. Waldrop M.F., Bell R.Q., McLaughlin B., Halverson C.F. Jr. Newborn minor physical abnormalities predict short attention span, peer aggression, and impulsivity at age 3. Science. 199:1978;563-564.
122. Wender P. Attention-deficit/hyperactivity disorder in adults. 1995;Oxford University Press, New York.
123. Werry J.S., Sprague R. Methylphenidate in children. Effects of dosage Australian and New Zealand Journal of Psychiatry. 8:1974;9-19.
124. Young E.S., Perros P., Price G.W., Sadler T. Acute challenge ERP as a prognostic of stimulant therapy outcome in attention deficit hyperactivity disorder. Biological Psychiatry. 37:1995;25-33.
125. Zahn T.P., Rapoport J.L., Thompson C.L. Autonomic and behavioral effects of dextroamphetamines and placebo in normal and hyperactive prepubertal boys. Journal of Abnormal Child Psychology. 8:1980;145-160.
126. Zametkin A.J., Rapoport J.L. Neurobiology of attention deficit disorder with hyperactivity. Where have we come in 50 years? Journal of the American Academy of Child and Adolescent Psychiatry. 26(5):1987;676-686.